Today: 19 December 2025
Subscribe
Browse Category

Pharma Industry News 8 December 2025 - 18 December 2025

Merck (MRK) Stock After Hours: FDA Fast‑Track Vouchers, Keytruda‑Padcev Trial Win, and What to Watch Before the Dec. 18 Market Open

Merck (MRK) Stock After Hours: FDA Fast‑Track Vouchers, Keytruda‑Padcev Trial Win, and What to Watch Before the Dec. 18 Market Open

Merck & Co., Inc. (NYSE: MRK) finished regular trading on Wednesday, Dec. 17, 2025 in positive territory, then held near the $99 level in extended hours as investors weighed two major pipeline headlines—one before the opening bell and another after
18 December 2025
 ·  ·  ·  ·  · 
Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy

Merck (MRK) Stock News Today: Why Shares Slid on Dec. 16, 2025 as Analysts Reassess Keytruda, Winrevair, and Merck’s Post‑Patent Strategy

Merck & Co., Inc. (NYSE: MRK) stock was among the biggest drags on the Dow Jones Industrial Average in Tuesday’s session (December 16, 2025), with shares trading lower as investors weighed broad market pressure alongside a fast-moving set of company-specific
16 December 2025
 ·  ·  ·  ·  · 
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Inc. (NYSE: ABBV) ended the week of Dec. 8–12, 2025 near $223, after a choppy stretch that featured two notable Wall Street moves—an HSBC upgrade and a Morgan Stanley price-target hike—alongside ongoing headlines tied to AbbVie’s oncology and neuroscience
14 December 2025
 ·  ·  ·  ·  · 
AbbVie Stock (ABBV) Weekly Update & Week-Ahead Outlook: Analyst Upgrades, Pipeline Catalysts, and Key Levels — Updated Dec. 12, 2025

AbbVie Stock (ABBV) Weekly Update & Week-Ahead Outlook: Analyst Upgrades, Pipeline Catalysts, and Key Levels — Updated Dec. 12, 2025

(SEO): AbbVie (NYSE: ABBV) ended the week at $223.32. Here’s what moved ABBV stock this week, the latest news, analyst forecasts and price targets, and what to watch in the week ahead. StockAnalysis Updated:Friday, December 12, 2025 (U.S. market close)
13 December 2025
 ·  ·  ·  ·  · 
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax Société Anonyme (Euronext Paris: ABVX, Nasdaq: ABVX) is back in the spotlight on December 10, 2025, after its share price spiked again on fresh takeover speculation involving U.S. pharma giant Eli Lilly. The move caps an extraordinary year in
10 December 2025
 ·  ·  ·  ·  · 
Eli Lilly Stock After Hours on December 9, 2025: 9‑Day Slide, $6B Alabama Bet and What to Watch Before the December 10 Open

Eli Lilly Stock After Hours on December 9, 2025: 9‑Day Slide, $6B Alabama Bet and What to Watch Before the December 10 Open

Eli Lilly and Company (NYSE: LLY) closed lower again on Tuesday, December 9, extending a rare nine‑session losing streak even as the drugmaker announced a multibillion‑dollar U.S. manufacturing expansion and positive cancer‑drug trial data. StockAnalysis+1 Heading into the U.S. stock
10 December 2025
 ·  ·  ·  ·  · 
1 2 3 … 5
Go toTop